Recurrent ventricular tachycardia after cardiac sympathetic denervation: prolonged cycle length with improved hemodynamic tolerance and ablation outcomes

ConclusionRFA for recurrent MMVT post ‐CSD is a reasonable treatment option with intermediate‐term clinical success in 50% of patients. Clinical VT cycle length was significantly increased after CSD with associated improvement in mappable, hemodynamically tolerated VT during RFA.This article is protected by copyright. All rights reserved.

Source: Journal of Cardiovascular Electrophysiology - June 16, 2020 Category: Cardiology Authors: Justin Hayase, Veronica Dusi, Duc Do, Olujimi A. Ajijola, Marmar Vaseghi, Jay M. Lee, Jane Yanagawa, Nir Hoftman, Sha'Shonda Revels, Eric F. Buch, Houman Khakpour, Osamu Fujimura, Yuliya Krokhaleva, Carlos Macias, Julie Sorg, Jean Gima, Ge Tags: ORIGINAL ARTICLES Source Type: research